This study is looking at whether a dietary supplement called ProGo® (salmon protein hydrolysate) can help women manage their weight and improve their overall quality of life during menopause. You might be able to join if you are a woman between 40 and 65 years old, are in the menopausal transition or post-menopause, and are considered overweight (with a Body Mass Index, or BMI, between 25.0 and 32.5 kg/m²). Participants will receive either ProGo® or a placebo (an inactive tablet that looks the same) daily for 18 weeks. The main goals are to see if ProGo® changes BMI and improves how you feel about your menopause symptoms. The study is currently unclear on its recruitment status and plans to enroll 100 participants.

Study design

This is an interventional study where 100 participants will be randomly assigned to receive ProGo® (at two different doses) or a placebo.

What's involved

Participants will take a tablet once daily for 18 weeks. Your BMI and menopause-specific quality of life will be measured at the end of this period.

Compensation

Not stated in the trial record.

Follow-up

Participants will be followed for 18 weeks, which is when the primary outcomes are measured.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.